Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.
OBJECTIVES:Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable severity and clinical course, characterised by progressive histological inflammation and with elevation of eicosanoids which have a known pathophysiological role in inflammation. Therapeutic in...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3799829?pdf=render |
id |
doaj-28fa51e5102849a884926378d24d766e |
---|---|
record_format |
Article |
spelling |
doaj-28fa51e5102849a884926378d24d766e2020-11-24T22:03:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7653210.1371/journal.pone.0076532Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.Mojgan MasoodiDaniel S PearlMichael EidenJanis K ShuteJames F BrownPhilip C CalderTimothy M TrebbleOBJECTIVES:Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable severity and clinical course, characterised by progressive histological inflammation and with elevation of eicosanoids which have a known pathophysiological role in inflammation. Therapeutic interventions targetting eicosanoids (5-aminosalicylates (ASA)) are effective first line and adjunctive treatments in mild-moderate UC for achieving and sustaining clinical remission. However, the variable clinical response to 5-ASA and frequent deterioration in response to cyclo-oxygenase (COX) inhibitors, has prompted an in depth simultaneous evaluation of multiple lipid mediators (including eicosanoids) within the inflammatory milieu in UC. We hypothesised that severity of inflammation is associated with alteration of lipid mediators, in relapsing UC. DESIGN:Study was case-control design. Mucosal lipid mediators were determined by LC-MS/MS lipidomics analysis on mucosal biopsies taken from patients attending outpatients with relapsing UC. Univariate and multivariate statistical analyses were used to investigate the association of mucosal lipid mediators, with the disease state and severity graded histologically. RESULTS:Levels of PGE2, PGD2, TXB2, 5-HETE, 11-HETE, 12-HETE and 15-HETE are significantly elevated in inflamed mucosa and correlate with severity of inflammation, determined using validated histological scoring systems. CONCLUSIONS:Our approach of capturing inflammatory mediator signature at different stages of UC by combining comprehensive lipidomics analysis and computational modelling could be used to classify and predict mild-moderate inflammation; however, predictive index is diminished in severe inflammation. This new technical approach could be developed to tailor drug treatments to patients with active UC, based on the mucosal lipid mediator profile.http://europepmc.org/articles/PMC3799829?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mojgan Masoodi Daniel S Pearl Michael Eiden Janis K Shute James F Brown Philip C Calder Timothy M Trebble |
spellingShingle |
Mojgan Masoodi Daniel S Pearl Michael Eiden Janis K Shute James F Brown Philip C Calder Timothy M Trebble Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. PLoS ONE |
author_facet |
Mojgan Masoodi Daniel S Pearl Michael Eiden Janis K Shute James F Brown Philip C Calder Timothy M Trebble |
author_sort |
Mojgan Masoodi |
title |
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
title_short |
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
title_full |
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
title_fullStr |
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
title_full_unstemmed |
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
title_sort |
altered colonic mucosal polyunsaturated fatty acid (pufa) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
OBJECTIVES:Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable severity and clinical course, characterised by progressive histological inflammation and with elevation of eicosanoids which have a known pathophysiological role in inflammation. Therapeutic interventions targetting eicosanoids (5-aminosalicylates (ASA)) are effective first line and adjunctive treatments in mild-moderate UC for achieving and sustaining clinical remission. However, the variable clinical response to 5-ASA and frequent deterioration in response to cyclo-oxygenase (COX) inhibitors, has prompted an in depth simultaneous evaluation of multiple lipid mediators (including eicosanoids) within the inflammatory milieu in UC. We hypothesised that severity of inflammation is associated with alteration of lipid mediators, in relapsing UC. DESIGN:Study was case-control design. Mucosal lipid mediators were determined by LC-MS/MS lipidomics analysis on mucosal biopsies taken from patients attending outpatients with relapsing UC. Univariate and multivariate statistical analyses were used to investigate the association of mucosal lipid mediators, with the disease state and severity graded histologically. RESULTS:Levels of PGE2, PGD2, TXB2, 5-HETE, 11-HETE, 12-HETE and 15-HETE are significantly elevated in inflamed mucosa and correlate with severity of inflammation, determined using validated histological scoring systems. CONCLUSIONS:Our approach of capturing inflammatory mediator signature at different stages of UC by combining comprehensive lipidomics analysis and computational modelling could be used to classify and predict mild-moderate inflammation; however, predictive index is diminished in severe inflammation. This new technical approach could be developed to tailor drug treatments to patients with active UC, based on the mucosal lipid mediator profile. |
url |
http://europepmc.org/articles/PMC3799829?pdf=render |
work_keys_str_mv |
AT mojganmasoodi alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT danielspearl alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT michaeleiden alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT janiskshute alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT jamesfbrown alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT philipccalder alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology AT timothymtrebble alteredcolonicmucosalpolyunsaturatedfattyacidpufaderivedlipidmediatorsinulcerativecolitisnewinsightintorelationshipwithdiseaseactivityandpathophysiology |
_version_ |
1725833135301591040 |